Need professional-grade analysis? Visit stockanalysis.com
$25.27B
52.75
9,065
1.53%
Zhejiang Huahai Pharmaceutical Co Ltd (600521) trades on SHG in CNY. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at CNY16.88, up 3.62% from the previous close.
Over the past year, 600521 has traded between a low of CNY14.13 and a high of CNY27.01. The stock has gained 16.5% over this period. It is currently 37.5% below its 52-week high.
Zhejiang Huahai Pharmaceutical Co Ltd has a market capitalization of $25.27B, with a price-to-earnings ratio of 52.75 and a dividend yield of 1.53%.
Zhejiang Huahai Pharmaceutical Co., Ltd. engaged in the research, development, production and sales of generic drugs, biological drugs, and APIs in multiple dosage forms in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also provides packaging components, such as polyethylene bottles and polypropylene caps for pharmaceuticals. In addition, the company offers contract manufacturing and other services, as well as import and export trade services. Further, it operates as a pharmaceutical company. Zhejiang Huahai Pharmaceutical Co., Ltd. was founded in 1989 and is headquartered in Linhai, China.
Side-by-side comparison against top Healthcare peers.